CAAP1
Caspase activity and apoptosis inhibitor 1
Also known as: C9orf82, CAAP, CAAP1_HUMAN, FLJ13657
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H8G2
- Gene
- CAAP1
- Ensembl
- ENSG00000120159
- Chromosome
- 9
- Canonical length
- 361 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
Involved in negative regulation of apoptotic process. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
361 residues, UniProt reviewed canonical sequence.
>Q9H8G2|CAAP1
1 MTGKKSSREK RRKRSSQEAA AALAAPDIVP ALASGSSGST SGCGSAGGCG SVSCCGNANF
61 SGSVTGGGSG GSCWGGSSVE RSERRKRRST DSSSVSGSLQ QETKYILPTL EKELFLAEHS
121 DLEEGGLDLT VSLKPVSFYI SDKKEMLQQC FCIIGEKKLQ KMLPDVLKNC SIEEIKKLCQ
181 EQLELLSEKK ILKILEGDNG MDSDMEEEAD DGSKMGSDLV SQQDICIDSA SSVRENKQPE
241 GLELKQGKGE DSDVLSINAD AYDSDIEGPC NEEAAAPEAP ENTVQSEAGQ IDDLEKDIEK
301 SVNEILGLAE SSPNEPKAAT LAVPPPEDVQ PSAQQLELLE LEMRARAIKA LMKAGDIKKP
361 ALocalizationUniProt · AlphaFold · HPA
Whether an antibody against CAAP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.64
- Highest tissue expression
- 26 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 26 nTPM
- liver: 22 nTPM
- adrenal gland: 19 nTPM
- rectum: 18 nTPM
- parathyroid gland: 18 nTPM
- colon: 17 nTPM
Single-cell type
- choroid plexus epithelial cells: 229 nCPM
- adrenal cortex cells: 139 nCPM
- distal convoluted tubule cells: 125 nCPM
- myonuclei: 124 nCPM
- renal connecting tubule cells: 122 nCPM
- lacrimal acinar cells: 109 nCPM
Immune cell
- MAIT T-cell: 21 nTPM
- NK-cell: 20 nTPM
- memory B-cell: 19 nTPM
- memory CD8 T-cell: 19 nTPM
- naive B-cell: 19 nTPM
- T-reg: 19 nTPM
Brain region
- choroid plexus: 19 nTPM
- hypothalamus: 6.8 nTPM
- cerebellum: 6.1 nTPM
- thalamus: 5.9 nTPM
- cerebral cortex: 5.8 nTPM
- white matter: 5.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.46
- gnomAD pLI
- 0.78
- gnomAD missense Z
- -0.47
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Protein domainsUniProt · Pfam · InterPro
- Caspase activity and apoptosis inhibitor 1
- Caspase activity and apoptosis inhibitor 1
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CAAP1 as an antibody target. Whether an autoantibody or antibody against CAAP1 could matter depends on whether native CAAP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CAAP1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CAAP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...